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Background: Thyroid hormones regulate growth and development. However, the molecular mechanisms by which
thyroid hormone regulates cell structural development are not fully understood. The mammalian cochlea is an
intriguing system to examine these mechanisms, as cellular structure plays a key role in tissue development, and
thyroid hormone is required for the maturation of the cochlea in the first postnatal week.
Results: In hypothyroid conditions, we found disruptions in sensory outer hair cell morphology and fewer
microtubules in non-sensory supporting pillar cells. To test the functional consequences of these cytoskeletal
defects on cell mechanics, we combined atomic force microscopy with live cell imaging. Hypothyroidism stiffened
outer hair cells and supporting pillar cells, but pillar cells ultimately showed reduced cell stiffness, in part from a lack
of microtubules. Analyses of changes in transcription and protein phosphorylation suggest that hypothyroidism
prolonged expression of fibroblast growth factor receptors, and decreased phosphorylated Cofilin.
Conclusions: These findings demonstrate that thyroid hormones may be involved in coordinating the processes
that regulate cytoskeletal dynamics and suggest that manipulating thyroid hormone sensitivity might provide
insight into the relationship between cytoskeletal formation and developing cell mechanical properties.
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The cytoskeleton plays a key role in modulating the
morphological changes of cells and tissues, impacting
both the resistance to deformation and the exertion of
force by the cell [1,2]. In the central nervous system,
thyroid hormones are thought to act as master regula-
tors of tissue growth and cytoskeletal development
[3,4]. Thyroid hormone action can be mediated through
traditional genomic mechanisms such as the regulation
of transcription [5,6] in association with co-activators
and co-repressors [7]. However, a direct transcriptional
regulation of cytoskeletal elements by thyroid hormone
receptors has not been described. This suggests that* Correspondence: Katherine.Szarama@stjude.org
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reproduction in any medium, provided the orthyroid hormones might act indirectly by controlling
intermediary signaling cascades, which could coordinate
the regulatory components of cytoskeletal formation [8,9].
The sensory epithelium of the mammalian inner ear is
an excellent model system to understand basic questions
of cytoskeletal organization, as structural elements, such
as actin and microtubules, facilitate the organization and
architecture of this tissue. The auditory epithelium of the
inner ear contains one row of inner hair cells and three
rows of outer hair cells (OHCs), which detect and amplify
sound, and several types of non-sensory supporting cells,
which withstand the mechanical stress of sound vibra-
tions. In particular, supporting pillar cells (PCs), which
form the fluid-filled tunnel of Corti [10], have a highly
organized cytoskeletal network composed primarily of
microtubules [11,12]. Disruptions in the formation of this
tunnel have been shown to negatively impact hearing
function [13-15]. Therefore, it is imperative that we
understand the regulatory cues that facilitate normal
structural development.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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signaling has an important role in development of the
cochlea. Both the sensory and supporting cells in this
epithelium have unique expression patterns of thyroid
hormone receptors [16,17], and deiodinase enzymes
[18,19], which control the availability of thyroid hor-
mone. More recently, thyroid hormone transporters
have also been localized to this sensory epithelium [20],
and the developmental expression profile contributes
some control over the accessibility of ligand to the
cell-specific targets. Consistent with this hypothesis, de-
letion of all known thyroid hormone receptors leads to
hearing impairment and inner ear cell structural defects,
including malformation of cells in the organ of Corti,
and a collapsed tunnel of Corti [14]. However, the
factors that mediate development of the inner ear struc-
tures are largely unknown. In the cochlea, cytoskeletal
formation, including the actin-based cuticular plate in
OHCs [11] and the dense 15-protofilament microtubule
network in PCs [21] that is mostly acetylated [12], fol-
lows cell differentiation [10-12]. However, the signaling
pathways mediating cell structural development are not
well understood.
Interestingly, mutations in some components of the
Fibroblast growth factor (Fgf ) signaling pathway cause
inner ear structural defects that appear similar to those
of the hypothyroid phenotype. In particular, mutations
in Fgf receptor 3 (Fgfr3) lead to disruptions in tissue
structure, including a collapsed tunnel of Corti, and
cause auditory defects in both mice and humans
[13,22-24]. These disruptions have been attributed to
both a lack of differentiation of PCs and malformation
in PC microtubule development [23]. However, there
must also be some regulation of Fgf-receptor expression.
One possibility that has been observed in other organ
systems is the impact of thyroid hormone regulation of
the Fgf-signaling pathway. For example, thyroid hormone
stimulates Fgfr expression in undifferentiated cartilage
[25,26]. Furthermore, a thyroid hormone response elem-
ent is present in the promoter region of Fgfr1 [27].
Together, these data suggest that Fgf-signaling could act
as an intermediary between thyroid hormone signaling
and cytoskeletal development, and motivate further exam-
ination of thyroid hormone action specifically in the
cochlea.
In this study, we examined the mechanism of thyroid
hormone action on inner ear structural development.
We found that hypothyroidism led to higher mRNA ex-
pression of Fgf-receptors relative to controls, leading to
a delay in the down-regulation of Fgfr3. Hypothyroidism
also led to delayed OHC and PC differentiation, which
may be mediated in part by the aberrant expression of
Fgf-receptors. Finally, hypothyroidism disrupted OHC
and supporting PC structure, and aberrantly stiffenedembryonic and early postnatal epithelial cells. Here, we
show that the hypothyroid-induced cell stiffening may
be mediated in part by the disrupted phosphorylation of
Cofilin, which has the potential to alter actin dynamics.
Results
Thyroid hormone levels regulate Fgfr expression in the
cochlea
To determine if Fgf-signaling is modulated by thyroid
hormones, we examined expression of two Fgf-receptors,
Fgfr1 and Fgfr3, in cochleae from mice with altered
thyroid hormone levels. To create a hyperthyroid condi-
tion, cochlear explant cultures were established at em-
bryonic day 14 (E14) and treated with triiodothyronine
(T3) for 2 or 4 days beginning after 24 hours in vitro.
Quantitative RT-PCR (qPCR) data showed a two-fold
decrease in Fgfr1 and Fgfr3 mRNA levels at both time
points (Figure 1A). As endogenous thyroid hormone de-
pletion takes considerably longer than thyroid hormone
stimulation in culture [28], we used pharmacological
agents to deplete thyroid hormones during development
in vivo. Pregnant female mice were rendered hypothyroid
with a combination of methimazole in the drinking water
and low iodine feed, which has previously been shown to
induce hypothyroidism in the cochlea in utero [29]. To
probe for changes in Fgf-receptors, mRNA was extracted
from inner ear sensory epithelia. Results from qPCR indi-
cated significant increases in both Fgfr1 and Fgfr3 mRNA
levels under hypothyroid conditions at both embryonic
day 16 (E16) and postnatal day 0 (P0) (Figure 1B). How-
ever, by postnatal day 3 (P3), while Fgfr1 expression was
six-fold greater in hypothyroid conditions relative to con-
trols, Fgfr3 expression was not significantly different from
controls (Figure 1B). These data are consistent with nega-
tive regulation of Fgfr expression by thyroid hormones
within the developing inner ear.
In order to localize the increase in expression of
these receptors in the cochlea, we examined Fgfr
mRNA expression by in situ hybridization in control
and hypothyroid cochleae. At P0, Fgfr1 is localized to
cell populations in both the greater epithelial ridge, a
collection of cells medial to the sensory epithelium
that gives rise to the inner sulcus [30], and the lesser
epithelial ridge, which is located lateral to the sensory
epithelium and gives rise to the spiral ligament [31]
(Figure 1C). In hypothyroid conditions, expression of
Fgfr1 appeared more intense at P0 relative to controls
at basal and apical regions of the cochlear duct
(Figure 1C). Expansion of the expression domain of
Fgfr1 was not observed. In contrast with Fgfr1, Fgfr3 is
normally initially expressed broadly within the sensory
epithelium in progenitors that will give rise to both
hair cells and supporting cells [32], but by P0 is down-
regulated in sensory OHCs of the more mature basal
Figure 1 Thyroid hormone levels regulate Fgf-receptor expression in the cochlea. (A) QPCR results show significantly decreased Fgfr1
(black) and Fgfr3 (white) expression upon treatment with thyroid hormone in vitro (*p-value < 0.05). (B) QPCR expression of Fgfr1 and Fgfr3 is
significantly increased when thyroid hormone levels are decreased in vivo (*p-value < 0.05). (C) In situ hybridization for Fgfr1 mRNA at P0 shows
increased expression in the greater (asterisk) and lesser (arrowhead) epithelial ridges in hypothyroid cochleae (right) relative to control (left).
(D) Fgfr3 mRNA levels at P0 persist in hypothyroid OHCs (right, arrowheads) relative to controls at the base of the cochlea (left, arrowheads).
Scale bar, 20 μm, applies to all images. OC, organ of Corti; OHC, outer hair cell.
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supporting pillar and Deiter’s cells (Figure 1D). At later
developmental time points, Fgfr3 expression in the
apex resembles expression in the base [33]. In
hypothyroid conditions, Fgfr3 expression in the base
persisted in OHCs at P0, indicating a delay in down-
regulation (Figure 1D). Taken together, these resultsshow that hypothyroidism leads to a delay in develop-
ment of the inner ear, and suggest that there may also
be a delay in differentiation of both OHCs and PCs at
postnatal stages.
As mentioned in the introduction, both gain and loss
of function mutations in Fgfr3 lead to deafness [24] and
prolonged Fgf-signaling delays PC development [23,32].
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regulation of Fgfr3, we hypothesized that there may be
delays in the maturation of this epithelium. One hall-
mark of differentiation is the formation and stabilization
of junctional complexes, which in the cochlea are com-
posed of adherens and tight junction proteins [34], in-
cluding Zonula-Occuludens 1 (ZO-1). In particular, ZO-
1 was recently characterized in this epithelium to beFigure 2 Hypothyroidism alters supporting pillar cell development. (A
unchanged relative to control (left) in hypothyroid conditions (right) at E16
shown by inset (box). Tight junction protein Zonula-Occludens 1 (ZO-1) im
and slightly decreased at P0 and P3. (B) Confocal micrographs of cross-sec
increased immunofluorescence in PCs under hypothyroid conditions (right
fluorescence intensity (mean ± s.e.m. A.U.) indicates increased phalloidin-lab
from P0 hypothyroid cochleae. The increased intensity of S100-A1 persists
CD44 decreases in PCs (box, inset) in hypothyroid cochleae at P6, suggestin
20 μm, applies to all confocal projections, which are representative of 6–9associated with maturation of OHC apical structure [35].
Therefore, we examined the downstream effect of
delayed maturation on immunofluorescence intensity of
labeled ZO-1 in control and hypothyroid cochleae.
Hypothyroid cochleae showed decreased immunolabel-
ing of ZO-1 relative to control conditions and this was
most apparent at E16 (Figure 2A), suggesting both a
delay in differentiation and disruption to cell structure.) Immunofluorescence for pillar cell marker p75ntr (pink; arrowhead) is
and P0, but persists in pillar cells (PCs) at postnatal day 3 (P3) as
munolabeling (green) is decreased in hypothyroid conditions at E16
tions immunolabeled for calcium-binding protein S100-A1 (pink) show
) at P3 and postnatal day 6 (P6). (C) Quantification of relative
eling in P0 OHCs and PCs and decreased S100-A1 in OHCs and PCs
in PCs as late as P6 (**p-value < 0.01, *p-value < 0.05). (D) PC marker
g that later differentiation of hypothyroid PCs is disrupted. Scale bar,
samples.
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expression of neurotrophin receptor p75 (p75ntr), an
early marker of developing PCs [36], was examined by
immunohistochemistry in cochlear cross-sections. P75ntr
is initially expressed in the cochlea at embryonic stages
of development [37], and is down-regulated postnatally,
which allows for specific labeling of early developing
PCs. Confocal images revealed that the onset of p75ntr
expression was not delayed at E16 or P0 (Figure 2A). In
contrast, at P3, p75ntr expression in the base of the
cochlea, which would normally be down-regulated, per-
sisted in hypothyroid samples (Figure 2A), consistent
with a delay in maturation of this supporting cell type.
Together, these results suggest that cochlear develop-
ment is delayed in the late embryonic period and PC
development is delayed at early postnatal time points.
To further assess postnatal PC development, expression
of S100-A1 protein was labeled and compared between
cochleae in hypothyroid and control conditions. S100 pro-
teins are initially highly enriched throughout the cochlear
duct at embryonic stages [38], and are later down-
regulated in differentiated PCs after the first postnatal
week. While S100-A1 immunofluorescence intensity
appeared to be lower in hypothyroid than in control con-
ditions at P0, by P3, S100-A1 immunofluorescence
appeared higher in hypothyroid than in control conditions
(Figure 2B), which is consistent with the developmental
delay observed in hypothyroid cochleae [14]. To quantify
this difference, measurements of relative fluorescence
intensity (mean ± s.e.m. A.U.) were calculated and com-
pared between hypothyroid and control conditions. In
PCs, S100-A1 intensity decreased from 987 ± 119 A.U.
in control conditions to 319 ± 116 A.U. in hypothyroid
conditions at P0, as was the case for the OHCs
(Figure 2C; p-value < 0.05). Later, at P6, expression of
S100-A1 was significantly increased from 609 ± 48 A.U.
in controls to 1257 ± 18 A.U. in hypothyroid conditions
(Figure 2C; p-value < 0.01) showing that disruptions in
these cells persist at later postnatal stages. Additionally,
the relative fluorescence intensity of phalloidin in
hypothyroid OHCs and PCs showed about a three-fold
increase relative to control conditions (Figure 2C;
p-value < 0.05).
Finally, to assess late postnatal differentiation of PCs,
we examined the relative immunofluorescence of CD44,
a protein that is restricted to supporting PCs at P0,
increases in intensity through P7 [39] and is reported to
be responsive to changes in thyroid hormone levels in
the cerebellum [40]. Confocal micrographs of cochlear
cross-sections at P6 showed that CD44 fluorescence
appeared lower in hypothyroid conditions relative to
controls (Figure 2D), suggesting that PCs maintain a
sensitivity to thyroid hormone levels during postnatal
development that may contribute to cell maturationbeyond the effects of Fgfr3. Taken together, these data
suggest that hypothyroidism leads to a delay in the tim-
ing of PC maturation, as early markers of development
that are normally down-regulated persist and late mar-
kers of development are delayed under experimental
conditions. Additionally, the corresponding delay in
down-regulation of Fgfr expression also suggests that
some of these early effects are mediated through
prolonged Fgfr expression.
Hypothyroidism disrupts microtubule formation in the
cochlea
Previous studies found that hypothyroidism reduces the
presence of tubulin in the developing central nervous
system [41,42]. Furthermore, we observed a delay in the
pattern of S100-A1 expression, which has been impli-
cated in microtubule formation in vitro [8,43]. There-
fore we asked if hypothyroidism also had consequences
for the structural development of PCs and OHCs. To
examine cellular structure, transmission electron micro-
graphs were collected from cross-sections of control
and hypothyroid cochleae. At P3, control PC cytoplasm
contained microtubules that are oriented longitudinally
from the lumenal surface to the basilar membrane
(Figure 3A). In contrast, PCs from hypothyroid cochleae
contained fewer microtubules (Figure 3A). Quantitative
analyses of the distribution of microtubules after con-
trolling for differences in cell width were calculated and
compared between control and hypothyroid conditions.
Analysis revealed a significant decrease in the mean
number of microtubules (mean ± s.e.m.) per micron cell
width in PCs in hypothyroid conditions (Figure 3B;
p-value < 0.05). To confirm this result, horizontal
sections from the lumenal surface of the PCs were also
examined and fewer microtubules were observed in
hypothyroid relative to control conditions (Figure 3C).
It is of note that the majority of microtubules at the
lumenal cell surface of PCs in hypothyroid conditions
localized to the lateral edge of the PC, whereas there
were microtubules observed throughout the cytoplasm
of control PCs (Figure 3C). As there was also a signifi-
cant increase in hypothyroid OHC phalloidin immuno-
fluorescence (Figure 2C), we investigated whether
hypothyroid conditions would also lead to structural
defects in OHC development. Transmission electron
micrographs indicated that hypothyroid OHCs were
shorter and wider in comparison to controls at P3
(Figure 3D). To quantify this difference, we measured
the average cell width and cell length (mean ± s.e.m. μm),
and found a significant increase in OHC width: length
ratio in hypothyroid cochleae (Figure 3E; p-value < 0.05).
Overall, the data suggest that hypothyroidism leads to
microtubule-based structural defects in supporting PCs
and morphological defects in sensory OHCs.
Figure 3 Hypothyroidism decreases microtubule formation and alters outer hair cell morphology. (A) Transmission electron micrographs
through cochlear cross-sections at P3 show fewer bundles of microtubules (asterisks) in hypothyroid PCs. (B) Quantification indicates fewer
microtubules per μm cell width at three different cell depths. (C) Horizontal sections representative of P3 PCs show homogeneous distribution of
microtubules (insets) at the lumenal surface of control conditions (left). In hypothyroid conditions, representative horizontal sections show a
decrease in total number of microtubules (right, arrowheads). (D) Micrographs of OHCs show that hypothyroid OHCs are shorter and wider than
controls. (E) Quantification of the average OHC aspect ratio (mean ± s.e.m.) shows a statistically significant increase in hypothyroid conditions
(*p-value < 0.001). Scale bar, 2 μm. OHC, outer hair cell; IHC, inner hair cell; PC, pillar cell; m, microvilli; P3, postnatal day 3.
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post-translational modifications such as acetylation
[12], which have consequences for both microtubule
stability [9] and cell structure [44]. To investigate the
effects of hypothyroidism on microtubule stability,
immunohistochemistry of acetylated tubulin was performed
on whole mount cochleae from control and hypothyroid
conditions. Confocal image analysis showed that acety-
lated tubulin immunofluorescence, a marker for stable
microtubules [45,46], was almost undetectable in the
PC region at P0 in hypothyroid cochleae (Figure 4A).
This was in contrast to control cochleae, which showedstrong immunolabeling of acetylated tubulin in PCs
(Figure 4A). Similar results were observed by P3 with
lowered overall fluorescence intensity levels of acety-
lated tubulin in hypothyroid PCs relative to control
conditions (Figure 4B). OHCs at P3 also contained a
microtubule-based kinocilium [47] that was identified
by the enrichment of acetylated tubulin (Figure 4B).
However, this structure was also observed under
hypothyroid conditions (Figure 4B), suggesting that
hypothyroidism does not delay formation or completely
disrupt microtubules in OHCs. Finally at postnatal day
5 (P5), there was an absence of acetylated tubulin
Figure 4 Acetylated tubulin decreases in hypothyroid cochleae. (A) Representative confocal projections of the lumenal surface of the
cochlear sensory epithelium from the apex of the cochlea at postnatal day 0 (P0). Acetylated tubulin immunofluorescence (pink) is decreased in
the PC row (dashed lines) of hypothyroid cochleae. Also, intensity of actin immunolabeling (green) appears increased in hypothyroid conditions.
(B) At postnatal day 3 (P3), acetylated tubulin immunolabeling is present in the hypothyroid PC row, but is decreased relative to control. Actin
immunofluorescence appears similar between control and hypothyroid conditions. (C) By postnatal day 5 (P5), acetylated tubulin expression
appears in supporting pillar and Deiter’s cells of control cochleae, but is absent in hypothyroid conditions. Scale bar, 20 μm, applies to
representative confocal projections from 12 samples. OHC, outer hair cell; PC, pillar cell; IHC, inner hair cell.
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cells (Figure 4C), a type of supporting cell with pro-
cesses that interdigitate between OHCs. These results
are consistent with a decrease in PC microtubule sta-
bility in response to hypothyroid conditions at all three
time-points tested.
Hypothyroidism stiffens outer hair cells and supporting
pillar cells
Previous cell and developmental biology studies suggest
that the cytoskeleton plays a role in the control of cell
shape [2] and, more recently, in dictating cell mecha-
nical properties [1]. The decreased microtubule forma-
tion (Figure 3), and alterations in microtubule stability
(Figure 4) of PCs, along with changes in morphology of
OHCs (Figure 3) raised the question of whether mech-
anical properties of these cells might also be altered in
hypothyroid conditions. To test this hypothesis, we
measured the mechanical properties of these cells in
culture with an atomic force microscope (Figure 5A).
Average Young’s modulus (mean ± s.e.m kPa), a measure
of the cellular resistance to deformation, was calculated
and compared between hypothyroid and controlcochleae at late embryonic and early postnatal time
points. We hypothesized that decreased cell structural
development would lead to a decrease in Young’s modu-
lus. However, Young’s modulus of OHCs actually showed
a trend towards increased stiffness in hypothyroid condi-
tions between E16 and P3 (Figure 5B) with this difference
becoming statistically significant at P3 (p-value < 0.05).
These results suggest that hypothyroid-related changes in
cell morphology stiffen OHCs.
To examine the effects of hypothyroidism on the
mechanical properties of developing PCs, we also
calculated average Young’s modulus for PCs in control
and hypothyroid conditions. We found that in con-
trols, PC Young’s modulus was approximately five-fold
higher between E16 and P5 (Figure 5C). This corre-
sponds to increased microtubule acetylation [48] and
suggests that increased cytoskeletal formation leads to
cell stiffening. In contrast with controls, hypothyroid
PCs were significantly stiffer at E16 and P0 (Figure 5C;
p-value < 0.05). However by P5, hypothyroid PCs
showed significantly reduced Young’s modulus relative
to controls (Figure 5C; p-value < 0.05). In summary,
these results indicate that hypothyroidism leads to a
Figure 5 Hypothyroidism stiffens outer hair cells and supporting pillar cells. (A) Schematic of Atomic Force Microscopy (AFM) experiments.
Organ of Corti explants were probed to determine surface mechanical properties of outer hair cells (OHCs) and supporting pillar cells (PCs) with
an AFM that measures the relative movement of a laser reflected from a cantilever probe onto a photodiode detector. (B) Average Young’s
modulus (mean ± s.e.m. kPa) was calculated for control and hypothyroid OHCs. OHCs in hypothyroid cochleae show a trend towards greater
stiffness that is significant relative to control conditions at P3 (*p-value < 0.05). (C) Average Young’s modulus is significantly increased in
hypothyroid PCs at E16 and P0. However, hypothyroid PCs have significantly reduced Young’s modulus by P5 relative to control conditions.
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that at later time points hypothyroid PCs fail to
develop mature mechanical properties.
Actin is responsible for the aberrant increase in pillar cell
and outer hair cell stiffness
The decreased stiffness of hypothyroid PCs at P5 is
consistent with the observed decrease in microtubules
(Figure 3) and lack of microtubule stability (Figure 4).
However, the hypothyroid PC stiffening at E16 and P0
and OHC stiffening at P3 were unexpected. One pos-
sible explanation for this effect could be the increase
in filamentous actin in response to decreased thyroid
hormone signaling, as observed by the increased phal-
loidin fluorescence intensity (Figure 2C). If actin
mediates cell mechanical properties, then disruptions
to the actin cytoskeleton should lead to decreased
cell stiffness in hypothyroid conditions. To test this
hypothesis, cochlear explants from control and
hypothyroid animals were treated with Latrunculin A,
a cell-permeant toxin [49] that sequesters actin mono-
mers [50] and depolymerizes actin filaments [49].
Consistent with this mechanism, cochleae treated at P0
with Latrunculin A showed decreased phalloidinimmunofluorescence (Figure 6A). In controls, a 30 minute
incubation with Latrunculin A resulted in a significant de-
crease in the average Young’s modulus (mean ± s.e.m.
kPa) of OHCs from 6.06 ± 0.64 kPa to 4.20 ± 0.31 kPa,
while PCs in the same samples were not significantly
different after treatment (Figure 6B; p-value < 0.01).
This suggests that the disruption to OHC actin and
reduced OHC stiffness does not also significantly dis-
rupt PC Young’s modulus. However, PCs maintained in
hypothyroid conditions and treated with Latrunculin A
showed a significant decrease in Young’s modulus at
both P0, from 4.93 ± 1.11 kPa untreated to 1.07 ± 0.08 kPa
after treatment, and at P3, from 9.83 ± 1.02 kPa
untreated to 2.48 ± 0.50 kPa after treatment (Figure 6D;
p-value < 0.001). OHCs maintained in hypothyroid
conditions also showed a decreased Young’s modulus in
response to Latrunculin A administration, which is
similar to results observed in euthyroid conditions.
However, the magnitude of the decreased OHC Young’s
modulus was much greater than in controls (Figure 6C;
p-value < 0.05), suggesting a greater sensitivity to actin dis-
ruptions in hypothyroid conditions. These results suggest
that PC surface mechanical properties in hypothyroid coch-
leae at E16 and P0 are mediated through changes in actin.
Figure 6 Hypothyroidism increases sensitivity of supporting cells to actin disruption. (A) Representative confocal z-projections of whole
mount explants treated at P0 with Latrunculin A show decreased phalloidin immunofluorescence relative to vehicle control. (B) In controls,
average Young’s modulus (mean ± s.e.m. kPa) of outer hair cells (OHCs, black) is significantly decreased with Latrunculin A treatment, while pillar
cells (PCs, blue) are not significantly different from Latrunculin A treatment at P0 (**p-value < 0.01). (C) Hypothyroid OHCs also have a decreased
Young’s modulus in treated conditions relative to vehicle control (*p-value < 0.05). (D) In contrast with controls, in which Latrunculin A treatment
did not affect PC Young’s modulus, hypothyroid PCs have a significant decrease in stiffness when treated with Latrunculin A (***p-value < 0.001).
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hypothyroid conditions
The results presented above suggested a relationship in
which thyroid hormone levels might be acting through
Fgfr-signaling to induce actin-based stiffening of
hypothyroid OHCs and PCs. Therefore, we explored
possible direct regulation of actin-modulating proteins
in response to activation of the Fgf-signaling pathway.
In particular, receptor tyrosine kinases have the po-
tential to mediate actin dynamics by controlling the
phosphorylation of Cofilin [51]. Cofilin, when not
phosphorylated by phosphorylated-Lim-domain kinase
(p-LIMK), can increase the turnover of actin leading to
increased polymerization of actin filaments [52-54]. To
examine the potential role of this pathway, total protein
was isolated from control and hypothyroid cochleae and
then probed with antibodies against phosphorylated and
total Cofilin protein. At E16, hypothyroid cochleae
appeared to have lower levels of p-Cofilin relative to
control (Figure 7A). To quantify this difference, the
average relative density (mean ± s.e.m. A.U.) of labeled
protein was calculated and compared between controland hypothyroid conditions. Total Cofilin was not
significantly different between control and hypothyroid
conditions (Figure 7A). A similar pattern of p-Cofilin at
E16 was also observed at P0, with p-Cofilin decreased
from 2.38 ± 0.23 A.U. in control to 0.68 ± 0.15 A.U. in
hypothyroid conditions (Figure 7B, p-value < 0.05). As
was the case for E16, total protein levels of Cofilin
were not significantly different between control and
hypothyroid cochleae at P0 and P3. By postnatal day 3
(P3), the relative intensity and average relative density
of p-Cofilin labeled proteins were now similar between
control and treated conditions (Figure 7C). These
results are consistent with the hypothesis that
hypothyroidism leads to prolonged Fgfr expression and
activation, which may have the effect of decreasing
phosphorylation of Cofilin and, as a result, to increasing
actin stability.
While the static localization of actin filaments has long
been understood to maintain cell shape and membrane
tension [55,56], the dynamics of actin treadmilling for
cell maturation and mechanics are just beginning to be
realized. In particular, the dynamic actin cytoskeleton is
Figure 7 Hypothyroidism leads to decreased phosphorylated Cofilin. (A) Representative western blots for protein isolated from embryonic
day 16 (E16) cochleae show decreased intensity of p-Cofilin in hypothyroid conditions relative to control. Total Cofilin appears to be unchanged.
Average relative density (mean ± s.e.m.) of phosphorylated, labeled proteins indicates decreased expression of p-Cofilin in hypothyroid cochleae.
Average relative density of Cofilin is not significantly different between control and hypothyroid. (B) At postnatal day 0 (P0), intensity of p-Cofilin
in hypothyroid conditions appears to be decreased relative to control conditions. Average relative density of p-Cofilin is significantly decreased in
hypothyroid relative to control conditions (*p-value < 0.05). (C) By postnatal day 3 (P3), the relative intensity and average relative density of
p-Cofilin labeled protein is unchanged between control and treated conditions. As for E16, total protein level of Cofilin is not significantly
different between control and hypothyroid cochleae at P0 and P3.
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http://www.biomedcentral.com/1471-213X/13/6primarily controlled by actin-binding proteins that regu-
late nucleation, polymerization and disassembly [57]. Spe-
cifically, the actin-depolymerizing factor, Cofilin, has been
shown to be necessary for actin filament assembly [58,59].
The results presented above demonstrated decreased
Cofilin phosphorylation during hypothyroidism. However,
changes in specific cell types could not be determined.
Therefore, in order to localize the observed changes in
p-Cofilin in hypothyroid cochleae, the expression of
p-Cofilin by immunofluorescence in cochlear cross-
sections at E16, P0, and P3 was examined. At E16,
expression of p-Cofilin was observed only in the nuclei
of OHCs and cells of the greater epithelial ridge, but
was present in both the cytoplasm and nuclei of
supporting pillar cells and cells of the lesser epithelial
ridge (Figure 8). This pattern of expression persisted in
both basal and apical sections of control conditions
through P3 (Figure 8). In hypothyroid conditions,
p-Cofilin immunofluorescence appeared to be reduced
in the sensory epithelium relative to controls at E16, P0,
and P3 (Figure 8). In particular, a marked reduction in
p-Cofilin was observed in PC cytoplasm and in OHC
nuclei at P0 and P3 (Figure 8). These data support a role
for lower Cofilin phosphorylation in the stabilization of
actin in PCs under hypothyroid conditions. The
localization of p-Cofilin in OHCs indicates that phos-
phorylation takes place predominantly in the nucleus,
which suggests that Cofilin is active primarily in the
dense actin meshwork of sensory OHCs, and mayFigure 8 Phosphorylated Cofilin localizes to the cochlear sensory epit
cross-sections through the organ of Corti at the indicated time points. P-Co
Immunofluorescence is present in the nuclei of cells in the greater epitheli
in the nuclei and cytoplasm of pillar cells (PCs, pink dotted lines) and cells
PCs of hypothyroid cochleae relative to control. Scale bar, 20 μm, applies to
cell; OHC, outer hair cell; LER, lesser epithelial ridge.explain in part the differences in OHC and PC
responses to hypothyroidism.
Discussion
Effects of thyroid hormone signaling in the inner ear may
be regulated through prolonged Fgf-signaling
Our data support previous findings that thyroid
hormone levels coordinate the timing of development in
many target tissues, including the skeletal [60] and
central nervous systems [61,62]. However, the specific
molecular pathways that mediate the effects of thyroid
hormone are largely still unknown. Thyroid hormones
primarily regulate transcriptional activity through
thyroid hormone receptors (reviewed in [63]). Based on
similarity in phenotypes and existing data from other
systems, we examined Fibroblast growth factor recep-
tors after altering thyroid hormone levels. In the organ
of Corti, decreased levels of thyroid hormone were
shown to result in prolonged expression of Fgfr1 and
Fgfr3, respectively (Figure 1), suggesting that thyroid
hormone receptors negatively regulate Fgf-receptor
expression in the developing cochlea. Interestingly,
Fgfr1 has been shown to accelerate differentiation when
inactivated in differentiating osteoblasts [64] and a
thyroid hormone response element has been identified
in the promoter region of Fgfr1 [27]. In the organ of
Corti, it seems that Fgfr3 regulates the timing of hair
cell and supporting cell development as shown by
experiments in which ectopic activation of Fgfr3 delayshelium and is decreased in hypothyroid conditions. Representative
filin is indicated by immunofluorescence in 12 μm projections.
al ridge (GER) and outer hair cells (OHCs, white dashed lines), as well as
of the lesser epithelial ridge (LER). P-Cofilin is decreased in OHCs and
all images. GER, greater epithelial ridge; IHC, inner hair cell; PC, pillar
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http://www.biomedcentral.com/1471-213X/13/6differentiation of supporting cells [23,32]. The observa-
tion of similar delays in the down-regulation of p75ntr
and S100 proteins (Figure 2) in differentiating cells in
hypothyroid conditions is consistent with the idea that
the maintenance of Fgfr3 signaling mediates at least
some of the effects observed in hypothyroidism of the
cochlea. However, these data do not rule out an
additional layer of regulation by thyroid hormones on
Fgf-signaling. Indeed, thyroid hormone has been shown
to play a role in heparin sulfate expression in the devel-
oping growth plate [65], which suggests an additional
pathway, through which thyroid hormone could
enhance Fgf-signaling. Overall, these findings suggest
that the timing of down regulation of Fgf-signaling is
important for the developing inner ear. However, the
persistent expression of both Fgfr3 and of Fgf8, the
most likely cognate ligand for Fgfr3 in the organ of
Corti, into adult stages, suggests that Fgf-signaling may
also have a continuous role in inner ear tissue mor-
phology. While it seems reasonable to suggest that the
mechanism to decrease Fgfr3-signaling would be to
decrease the presence of ligand [66,67], we propose that
thyroid hormones might also mediate Fgf-signaling at
this stage of inner ear development by regulating the
level of Fgf-receptor expression in the organ of Corti.
Using the drug methimazole, hypothyroidism was
induced in utero to examine the cellular response to a
lack of thyroid hormone in the organ of Corti. Thyroid
hormone levels in utero are thought to be primarily
from a maternal source and transmitted through the
placenta [68,69]. Methimazole transmission has also
been shown to cross the placenta [70] and to reduce
the serum levels of thyroid hormone [71]. While the
effectiveness of this drug has led to widespread use as
a treatment in clinical cases of hyperthyroidism for adults
and, in particular, during pregnancy [72], methimazole is
not without side effects. In less than 1% of human subjects,
agranulocytosis, a lowered white blood cell count, and liver
toxicity resulting in jaundice were reported [73,74]. How-
ever, considering the relatively limited time course of
methimazole treatment in these studies, it seems unlikely
that the treatment led to these side effects.
Thyroid hormone may disrupt cytoskeletal formation
through prolonged Fgf-signaling
A key observation of the experiments described here
was the alteration in cytoskeletal formation in response
to hypothyroidism. While disruption of the cytoskeleton
in cases of hypothyroidism has long been known
[3,7,42], the molecular basis for these effects is not yet
fully understood. The results presented here suggest
that Fgf signaling may act as an intermediary, with
prolonged Fgf-signaling leading to disruptions in micro-
tubule formation. In the case of microtubule structure,we extend existing research by providing two comple-
mentary mechanisms for this hypothyroid-induced
structural defect. First, deletion of Fgfr3 leads to
decreased β-tubulin [23], further supporting the
relationship between Fgf-signaling and microtubule
number. Second, the increase in S100-A1 in PCs is rep-
resentative of elevated intracellular calcium levels
[75,76], which could directly impair microtubule forma-
tion and is observed in Fgfr3-deficient mice [77].
In addition to the microtubule disruptions in PCs
(Figures 3 and 4), there also appeared to be a higher
fluorescence intensity of phalloidin-labeled actin in
hypothyroid conditions relative to controls. Phalloidin, a
member of the phallotoxin group of F-actin binding
peptides, has been used to quantify the amount of
F-actin in cells [78,79]. This probe has a diameter of
12–15 Å [80], which has the advantages of low steric
hindrance to bind close to a 1:1 ratio [80] and therefore
does not compete with actin binding proteins [81]. This
probe also has a similar affinity for both large and small
filaments [82], but does not bind monomeric G-actin.
This is a limitation of the technique as it is not possible
with only one probe to examine whether or not the ratio
of F-actin-to-G-actin has been altered in hypothyroid
relative to control conditions. However, the advantages
of this probe support our conclusion that stronger phal-
loidin fluorescence intensity, combined with electron
micrographs showing no apparent difference in cuticu-
lar plate thickness, suggests that there is a higher dens-
ity of actin, which may cause in part measured stiffening
at the lumenal surface of the cochlea.
There is increasing evidence that Fgf-signaling
mediates actin dynamics through signaling [83], which
may be the key link between hypothyroidism and the
observed cell structural defects. Indeed, Fgf-signaling is
necessary for the dynamic changes in actin remodeling
that lead to invagination of the developing otocyst [84].
In the hypothyroid cochlea, Fgf-receptors might medi-
ate actin dynamics through activation of p21-activated
kinases (PAKs) or ROCK [85,86] that can then phos-
phorylate LIMK to inhibit Cofilin activity via phosphor-
ylation [87,88]. The prolonged Fgfr-expression shown in
hypothyroid conditions coincides with a decrease in
phosphorylation of Cofilin (Figure 7), which is consist-
ent with the role for this protein in the rate of actin fila-
ment turnover. Since both increased actin filaments and
decreased Cofilin phosphorylation were observed in
hypothyroid cochleae, these results are consistent with
this proposed mode of regulation. This might in part ex-
plain the disruption to OHC morphology (Figure 3),
which is interesting given that recently it has been pro-
posed in other developing tissues that the rear-
rangement of actin filaments generally would produce a
disruption in cell morphology [89]. Additionally, disrupted
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dynamics through down-regulation of Rho-GTP signaling
[90]. Since p75ntr expression appeared to persist in
hypothyroid conditions at P3 (Figure 2), the contribution
of Fgf-signaling may also contribute indirectly through a
p75ntr-dependent mechanism.
Alterations in cytoskeletal dynamics may affect cell
mechanical properties
Ultimately, impaired functional ability of supporting PCs to
resist deformation at P5 (Figure 5) is not exactly concomi-
tant with the decrease in microtubule number observed in
electron micrographs of hypothyroid pillar cells relative to
controls. However, it is possible that the lack of acetylation
observed at P5 (Figure 4), and not absolute microtubule
number, contributes to the formation of the tunnel of Corti
by the pillar cells. It is also possible that a lack of acetylation
has other effects on microtubule length and polymerization
[91,92]. Future studies directly disrupting acetylation, while
also controlling for microtubule length and protofilament
number, will add important in vitro data that can be
brought back into microtubule-based cell structural assays
to further support what has been shown here.
In the case of actin structure, the findings that
hypothyroid OHCs and PCs are aberrantly stiffer than
controls (Figure 5) and are increasingly sensitive to
Latrunculin A (Figure 6) implicate the actin cyto-
skeleton, rather than microtubule development, in
hypothyroid-induced cell stiffening observed from E16
to P3. In this study, atomic force microscopy (AFM)
has been used to probe cytoskeletal structures in
living cells without membrane disruption or fixation.
While the cell membrane is an integral part of stabil-
izing the cytoskeleton, previous results have shown that
membrane stiffness is negligible in eukaryotic cells relative
to cytoskeletal stiffness [93,94]. Furthermore, with increas-
ing indentation depth—in this study indentation was
1.5 μm—the bulk of Young’s modulus has been shown to
be the result of cytoskeletal stiffness [48], and in the case
of the developing cochlea, reflects the stiffness of the actin
mesh at the cell apex. Indeed, by combining AFM with
live-cell fluorescence imaging techniques, it is possible to
get single cell specificity. For example, after treatment
with the cytoskeletal disrupting agent Latrunculin A, the
OHC but not the neighboring PC Young’s modulus was
decreased in cochlear explant cultures. Overall, these
AFM data suggest that the calculated Young’s modulus
reflects cell surface mechanical properties, which are
dominated by cytoskeletal components.
Cell-specific responses to thyroid hormone may lend
insight into cell structural development
While data presented here were only able to measure
the consequences of disrupted actin dynamics in haircells and supporting PCs, disruptions to actin dynamics
could have broad consequences for many supporting cell
types in the developing organ of Corti. For example, the
greater epithelial ridge is composed of columnar epithe-
lial cells that undergo structural changes leading to the
formation of the fluid filled space known as the inner
sulcus [95]. While we know that these cells support syn-
apse formation of sensory inner hair cells in the organ of
Corti [96,97], the aberrant cell cytoplasm in this region
may explain part of the pathology of hypothyroidism. By
localizing phosphorylated Cofilin expression in control
and hypothyroid cochlear cross-sections (Figure 8), we
observed not only the aberrant defect in the sensory
epithelium, but also the cell-specific differences in phos-
phorylated cofilin expression throughout the cochlear
duct. Cofilin phosphorylation has also been observed to
mediate actin dynamics in a number of developing sys-
tems [98,99]. The relationship between hypothyroidism
and cell-structural defects in the developing cochlea
might prove to be the basis for additional studies of
morphogenesis in developing systems that rely on co-
ordination by thyroid hormones [60,62]. Future studies
also examining actin dynamics under reduced thyroid
hormone levels could lend insight into a mechanism by
which developmental malformations to the structure
and function of the organ of Corti may be prevented.
Conclusion
We find that hypothyroidism leads to a delay in the
down-regulation of Fgf-receptors and to a decrease in
microtubule formation and acetylation at early postnatal
stages. While the lack of microtubules ultimately
reduce supporting pillar cell stiffness, we find that
hypothyroidism actually stiffens outer hair cells at P3
and pillar cells at E16 and P0 as a result of increased F-
actin. Our data also show that the increased dynamics
of actin in these cells might be the result of
hypothyroid-induced Fgf signaling and a decreased
phosphorylation of Cofilin. Together, these data impli-
cate the sensitivity of cell structural development to
thyroid hormones, and suggest that thyroid hormone
signaling might coordinate the time-course of tissue
morphogenesis.
Methods
Cochlear explant cultures and pharmacological
treatments
Cochleae of Institute for Cancer Research (ICR) mice
(Charles River Laboratories, Frederick, Maryland, USA)
were cultured at specific stages between E16 and P5 as
previously described [76] and plated on No.1 glass cov-
erslips (Corning, New York, USA). To increase thyroid
hormone signaling, explants were treated with either
5 μM triiodothyronine or 5 μM reverse triiodothyronine
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thyroid hormone, as a control, in DMSO. To decrease
thyroid hormone signaling, animals were treated with
0.02% methimazole (Sigma) and 10% sucrose in drink-
ing water and low iodine feed administered ad libitum.
All animal care and procedures were approved by the
Animal Care and Use Committee at NIH and complied
with the NIH guidelines for the care and use of animals.
Transmission electron microscopy
Cochleae from 3 control and 3 hypothyroid animals at P3
were isolated and placed immediately in 0.1 M phosphate
buffer (pH 7.4) containing 4% paraformaldehyde and 2%
glutaraldehyde for 30 minutes at room temperature fol-
lowed by 2 hours at 4°C. The inner ears were then washed
in phosphate buffer and cacodylate buffer, post-fixed with
1% osmium tetroxide, and dehydrated through a graded
alcohol series before being embedded in Poly/BED 812
resin (Polysciences Inc., Warrington, Pennsylvania, USA)
as previously described [48]. Thin sections of about 75 nm
were cut using a Leica Reichert ultramicrotome, stained
with lead citrate, mounted on 200-Cu mesh grids, and
examined at room temperature using a JEOL transmission
electron microscope (Akishima, Tokyo, Japan) at 80 kV
with 15,000× magnification. Images were acquired using a
Hamamatsu Camera (Hamamatsu Photonics K.K., Japan)
and Advanced Microscopy Techniques Camera System
software version 534.4 (Woburn, Massachusetts, USA).
Images were cropped in Adobe Photoshop CS4 (Adobe).
To quantify morphological changes in OHCs and PCs,
transverse sections from three animals for each condition
were analyzed with ImageJ [100] analysis software for the
presence of microtubules at distances 2, 4, and 6 μm from
the lumenal surface of PCs. Measurements of OHC length
and width were also made. Analysis of statistical signifi-
cance was determined using student’s T-test.
Immunohistochemistry and confocal image analysis
Samples of the same time point were harvested on the
same day under the same conditions, fixed in 4% para-
formaldehyde for 4 hours, rinsed, passed through an
increasing sucrose gradient, and embedded in OCT
(Sakura, New York, USA) in parallel. All sections to be
examined from the same time point for comparison
were cryosectioned at 12 μm thickness on the same day.
Sections were processed in parallel with the same stock
solutions, which included permeabilization with 0.2%
Tween-20 in PBS, blocking with 10% normal horse serum
and incubation overnight in primary antibody (p75ntr,
Covance, Princeton, New Jersey, USA, 1:1000; ZO-1,
Millipore, 1:1000, S100-A1, Neomarkers, Kalamazoo,
Michigan, USA, 1:500; CD44, BD Pharmigen, Franklin
Lakes, New Jersey, USA, 1:200; p-Cofilin, Santa Cruz
Biotechnology, Santa Cruz, California, USA, 1:500 ) at4°C. Primary antibodies were detected using either
Alexa Fluor 488 or 546 (Invitrogen, 1:1000) conjugated
secondary antibodies. Directly conjugated Phalloidin
633 (Invitrogen, 1:5000) was applied to all samples.
Cochleae prepared for whole mount immunohisto-
chemistry were fixed for 2 hours and were labeled with
a primary antibody against acetylated tubulin (Sigma,
1:750). Samples were mounted in Fluoromount-G
(Southern Biotech, Birmingham, Alabama, USA), using
No. 1½ glass coverslips (Corning, New York, USA)
adhered with nail polish. All fluorescence images were
acquired at room temperature with LSM 510 acquisition
software as 12 μm Z-stacks with 1 μm optical sectioning
using a Zeiss 510 LSM Confocal Microscope with 40X
oil objective [1.3 numerical aperture (NA); Plan-Neofluar].
Using line scan analysis, fluorescence intensity was
measured from projected Z-stacks with ImageJ [100]
analysis software in 2 μm areas at the lumenal surfaces
of both PCs and OHCs, as this region was previously
observed with Transmission Electron Microscopy to
maintain a homogeneous cell cytoplasm from E16
through P5 [48]. Average fluorescence intensity (mean ± s.e.
m. Arbitrary Units) was calculated from 6 samples, and
compared using student’s T-test.
In situ hybridization
Cochleae from 6 animals per condition—hypothyroid or
control—were harvested on the same day at the same time
point and fixed in a stock solution of 4% paraformalde-
hyde in 1X PBS overnight. Samples were then rinsed,
passed through an increasing sucrose gradient, and em-
bedded in OCT (Sakura, New York, USA) in parallel using
the same solutions under the same conditions. Samples
were cryosectioned in parallel at 12 μm thickness. All
steps of the in situ hybridization were carried out in paral-
lel on 6 sections from 6 animals per condition as pre-
viously described [93] with probes specific to Fgfr1 and
Fgfr3. All samples had the same exposure to the same
reaction mixture, as previously described [101] for the
same length of time.
Quantitative real-time polymerase chain reaction (qPCR)
Cochleae were removed from the temporal bone, and
the surrounding mesenchyme, scala vestibuli and scala
tympani were removed. 6–8 cochleae were pooled and
total RNA was isolated using RNAqueous (Ambion,
Grand Island, New York, USA) reagents. cDNA was
synthesized from 500 ng total RNA for each condition
using a Superscript III first strand synthesis kit (Invitrogen).
Amplification was performed with SYBR Green (Applied
Biosystems, Foster City, California, USA). Amplification of
all mRNA was performed on an ABI Prism 7000 (Applied
Biosystems) with the following cycling conditions:
40 cycles of 95°C for 15 seconds, and 60°C for 1 minute.
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ized to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) and statistical significance was confirmed
with student’s T-test. Primer sequences used are as fol-
lows: Fgfr1,F 3′-ATGGTTGACCGTTCTGGAAG-5′;
Fgfr1,R 3′-AGAAAAGGGTACGCAGCAGA-5′; Fgfr3,
F 3′-GAGACTTGGCTGCCAGAAAC-5′; Fgfr3, R 3′-
GGGCTCACATTTGTGGTCTT-5′, GAPDH, F 3′-AT
CCTGTAGGCCAGGTCATG-5′; GAPDH, R 3′-TATG
CCCGAGGACAATAAGG-5′.
Western blot analysis
Cochlear explants were freshly isolated before total
protein extraction. Proteins were extracted from 8–10
cochleae in RIPA buffer containing complete mini pro-
tease inhibitor cocktail (Roche), complete phosphatase
inhibitor cocktail (Roche), 1 mM Na3VO4, and 500 mM
NaF. Protein was quantified using the Dc protein assay
kit (Bio Rad) and Lowry method using a ND-1000
Spectrophotometer (Nanodrop, Wilmington, Deleware,
USA). 25 μg total protein per condition was loaded onto
4-12% SDS-PAGE gels (Invitrogen) run for 2 hours at
120 V, transferred to nitrocellulose membrane (Invitrogen),
and run for 3 hours at 80 V at 4°C. Membranes were
blocked in 0.05% TBS-T containing BLOTTO (Rockland,
Gilbertsville, Pennsylvania, USA) and 1% BSA (Sigma).
Primary antibodies were incubated in blocking solution
at the following concentrations: p-Cofilin (1:500,
Abcam); Cofilin (1:5000, Abcam). Primary antibodies
were conjugated to horseradish peroxidase anti-rabbit
secondary antibody (1:5000, Amersham) and detected
using ECL Detection Reagents (Amersham). Mem-
branes were visualized using Image Station 4000R
(KODAK) and Carestream Molecular Imaging Software
(New Haven, Connecticut, USA). Image analysis was
performed with ImageJ [100] using the Gel Analysis
plug-in method to calculate relative density. Relative
density of phosphorylated protein signal was normalized
to β-actin (Sigma, 1:5000) signal for the same tissue and
under the same experimental conditions. Statistical
significance was determined with Welch’s T-test [102].
Atomic force microscopy and live cell imaging
Experiments were performed using a Bioscope II and
Bioscope Catalyst AFM (Bruker, Santa Barbara, California,
USA) head mounted onto a Zeiss Axiovert 200 inverted
microscope and controlled via a Nanoscope V control-
ler. Pyramidal shaped, gold-coated, silicon nitride canti-
lever probes with 0.03 N/m spring constant (Bruker)
were used for all measurements. Cells were identified
after being loaded with 500 nM Calcein AM vital dye
(Invitrogen) in Leibovitz’s media (Invitrogen) for 30 min-
utes and rinsed with fresh Leibovitz’s media. Contact
mode AFM was applied to all samples in Leibovitz’smedia at 1.5 μm maximum indentation using 3 μm
ramps at 1 Hz continuous force ramping to collect 3
force-distance curves for the center of each identified
hair cell or supporting cell. All force-distance curves
were analyzed with custom analysis software in
MATLAB (Mathworks, Natick, Massachusetts, USA)
and fit to the Sneddon model [103] to measure Young’s
modulus, which is a material property of the cellular
resistance to deformation and was calculated with the
formula F = (2/πtanα)(E/(1-ν2))δ2; where F is applied
force, ν is Poisson’s ratio and assumed to be 0.5, δ is
cantilever indentation, and α is cantilever tip angle.
Average Young’s modulus (mean ± s.e.m. kPa) was
calculated from the average of sample measurements of
10 cells within a given region of interest such as the
base or the apex of the cochlea. Statistical analyses were
performed using Welch’s T-test [102].
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